試す 金 - 無料
Fountain of youth
Healthcare Radius
|May 2023
The demand for anti-aging products and procedures is going through the roof. Science is helping.
Is anti-aging more than a pipe dream? Going by the variety of products on the shelves of shops selling cosmetics, it is not. According to Customer Market Research, a market research firm, the global anti-aging market was valued at $60 billion (Rs 4.93 lakh crore, approximately) in 2021 and is expected to double by 2030, reaching $120 billion (about Rs 9.85 lakh crore).
The Asia Pacific anti-aging market stood at 8.09 billion (Rs 66388.84 crore, approximately) in 2022 and is slated to grow by 5.69 percent to reach 10.66 billion (Rs 87,478.46 crore, roughly) by 2027, according to another research firm, Market Data Forecast. The Indian anti-aging market is the fastest-growing and is predicted to grow at a CAGR of 12 percent during the forecast period (2022 to 2027). Changing lifestyles, advancements in cosmetics, and escalating healthcare expenditures are majorly driving this market growth in India.
In 2021, skincare dominated the market, accounting for about 41 percent of the global market share, while haircare and cosmetics accounted for 22 percent and 16 percent, respectively. The expanding economy of India allows consumers to purchase anti-aging products and services, thus, boosting the market growth in both. Also, e-commerce sites and social media present opportunities and attract more customers.
A play of products
Arushi Jain, Director, Akums Drugs & Pharmaceuticals, says, "From anti-aging creams and under-eye creams to hydro-boasting face serums, the market is flooded with skincare products. Some popular formats are anti-aging face cleansers, anti-aging creams, Retinol serums, under-eye creams and serums, face packs, night creams, hydrating toners, and lip serums. Effectiveness of all these depends upon the quality of ingredients chosen to formulate the products."
このストーリーは、Healthcare Radius の May 2023 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、10,000 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
Healthcare Radius からのその他のストーリー
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Translate
Change font size
